# FDA Compliance Fix Status

## ✅ COMPLETED (Phase 1 - Critical)

### Automated Fixes Applied:
1. ✅ Removed "bacteriostatic water" → replaced with "appropriate research diluent" 
2. ✅ Removed "clinical-grade" → replaced with "research-grade"
3. ✅ Removed "forensic-grade" → replaced with "analytical-grade"
4. ✅ Removed "discreet, unmarked packaging" → replaced with "professional packaging"
5. ✅ Removed specific human dosing protocols (250mcg daily for 28 days, etc.)
6. ✅ Removed "complete research cycle" → replaced with "research protocol"
7. ✅ Archived all GLP-1 comparison articles (moved to blog/ARCHIVED_FDA_RISK/)
8. ✅ Removed "Free laboratory solvent kit" → "Research documentation included"
9. ✅ Removed Zelle 5% discount marketing language from main pages

### Files Modified:
- All .html files in root, products/, and blog/ directories
- Archived 6 comparison articles

## ⚠️ NEEDS MANUAL REVIEW

### checkout.html Zelle Discount Logic:
- **Issue:** Actual 5% discount still coded in checkout
- **Risk Level:** HIGH - DOJ flagged Zelle steering in peptide enforcement
- **Recommendation:** Remove discount logic entirely or reduce prominence
- **Location:** Lines 775, 1054, 1140-1142

### Terms Entity Name:
- **Status:** ✅ Already says "Vantix Bio" (not PRC LABS LLC)
- **No action needed**

### Pricing Inconsistencies:
- Homepage vs Shop vs Kits pages
- Need systematic audit (not FDA risk, just operational)

## 🔬 RESEARCH CONTENT UPDATES NEEDED

### Product Pages Needing Citation Verification:
1. products/bpc-157.html
2. products/tb-500.html  
3. products/retatrutide.html
4. products/tirzepatide.html
5. products/semaglutide.html
6. products/nad-1000mg.html
7. products/ghk-cu.html
8. products/mots-c.html
9. products/cjc-1295.html
10. products/ipamorelin.html
11. products/tesamorelin.html
12. products/aod-9604.html

### Blog Articles Needing Citation Audit:
- All remaining blog/*.html files (20+ articles)
- Priority: Articles with PMID citations
- Check for hallucinated references
- Add 2024-2026 studies where relevant

### Key Research Updates Needed:
1. **Retatrutide:** SURMOUNT-2, SURMOUNT-3 (2024 data)
2. **Tirzepatide:** Latest SURPASS/SURMOUNT outcomes
3. **Semaglutide:** SELECT CV outcomes (2023)
4. **BPC-157:** Any new mechanistic studies 2024-2026
5. **TB-500:** Tissue engineering applications
6. **NAD+:** Longevity/mitochondrial research
7. **MOTS-c:** Exercise/metabolic studies

## NEXT STEPS

### Immediate (Deploy Now):
1. Commit automated fixes
2. Push to production
3. Test key pages load

### Short-term (This Week):
1. Decide on Zelle discount removal
2. Product page benefit language audit
3. Citation verification protocol

### Medium-term (Next 2 Weeks):
1. Systematic research update
2. Add 2024-2026 studies
3. Complete citation verification

## LEGAL REVIEW RECOMMENDATION

Before launch, consider having peptide-specialized attorney review:
- Homepage
- Shop page  
- 2-3 sample product pages
- Terms of service
- Any remaining blog articles

Cost: ~$500-1,000 for limited review
Benefit: Defense if Warning Letter arrives
